• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Kimball Electronics, Inc. Announces Appointment of Additional Director

    9/15/22 4:05:00 PM ET
    $BHC
    $KE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Electrical Products
    Technology
    Get the next $BHC alert in real time by email

    Kimball Electronics, Inc. (NASDAQ:KE), announces the expansion of its Board of Directors and appointment of a new director at its regularly scheduled Board Meeting on September 13, 2022.

    Tom Vadaketh was selected to the Company's Board of Directors (the "Board"), effective as of the September meeting. Mr. Vadaketh will serve on the Audit Committee and will stand for election to a full term at the 2022 Annual Meeting of Share Owners in November.

    Mr. Vadaketh serves as Chief Financial Officer of Bausch Health (NYSE:BHC) (TSX:BHC), which develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices globally, primarily in the therapeutic areas of eye-health, gastroenterology, and dermatology.

    Prior to joining Bausch Health in January 2022, Mr. Vadaketh served as Executive Vice President and Chief Financial Officer of eResearch Technology, Inc. from September 2018 to December 2021, where he was responsible for leading the Finance function including controllership, treasury, taxation, and financial planning.

    Prior to that, he was Executive Vice President and Chief Financial Officer of Cambrex Corporation. In addition, Mr. Vadaketh spent over 20 years at Procter & Gamble and Tyco International, where he held several roles of increasing responsibility at both companies.

    Mr. Vadaketh received a degree from the Institute of Chartered Accountants in England and Wales (ACA) and an M.B.A. from Manchester Business School. He is a Certified Public Accountant.

    "Speaking on behalf of our Board, it is an honor to have Tom join us with his well-rounded financial expertise, vast experience with major multinational organizations, and demonstrated leadership in a variety of global businesses driving both organic growth and strategic acquisitions," said Don Charron, Chairman of the Board and Chief Executive Officer. "Tom further enhances our Board's distinct and valuable skill sets as we continue to build lasting relationships and global success with our stakeholders. We expect to learn a lot from Tom so that we become an even better company while creating quality for life."

    About Kimball Electronics, Inc.

    Kimball Electronics is a multifaceted manufacturing solutions provider of electronics and diversified contract manufacturing services to customers around the world. From our operations in the United States, China, India, Japan, Mexico, Poland, Romania, Thailand, and Vietnam, our teams are proud to provide manufacturing services for a variety of industries. Recognized for a reputation of excellence, we are committed to a high-performance culture that values personal and organizational commitment to quality, reliability, value, speed, and ethical behavior. Kimball Electronics, Inc. (NASDAQ:KE) is headquartered in Jasper, Indiana.

    To learn more about Kimball Electronics, visit: www.kimballelectronics.com.

    Lasting relationships. Global success.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20220915005963/en/

    Get the next $BHC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BHC
    $KE

    CompanyDatePrice TargetRatingAnalyst
    Kimball Electronics Inc.
    $KE
    8/15/2024Buy → Neutral
    Sidoti
    Bausch Health Companies Inc.
    $BHC
    8/2/2024$9.00 → $3.00Neutral → Underweight
    Piper Sandler
    Bausch Health Companies Inc.
    $BHC
    7/10/2024$8.00Mkt Perform
    Raymond James
    Kimball Electronics Inc.
    $KE
    10/9/2023$39.00Buy
    B. Riley Securities
    Bausch Health Companies Inc.
    $BHC
    9/20/2023$9.00 → $16.00Hold → Buy
    Jefferies
    Bausch Health Companies Inc.
    $BHC
    6/16/2023Outperform → Market Perform
    TD Cowen
    Kimball Electronics Inc.
    $KE
    6/15/2023$3.40Overweight
    Cantor Fitzgerald
    Bausch Health Companies Inc.
    $BHC
    7/29/2022Buy → Hold
    Truist
    More analyst ratings

    $BHC
    $KE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Paulson John bought $312,490,062 worth of shares (34,721,118 units at $9.00) (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    8/14/25 9:35:28 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Paulson John bought $21,267,731 worth of shares (3,243,049 units at $6.56) (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    8/13/25 6:51:24 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Paulson John bought $21,170,510 worth of shares (3,564,059 units at $5.94) (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    6/17/25 4:44:09 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BHC
    $KE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Paulson John bought $312,490,062 worth of shares (34,721,118 units at $9.00) (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    8/14/25 9:35:28 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider Paulson & Co. Inc. claimed ownership of 70,755,869 shares (SEC Form 3)

    3 - Bausch Health Companies Inc. (0000885590) (Issuer)

    8/14/25 9:32:11 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Paulson John bought $21,267,731 worth of shares (3,243,049 units at $6.56) (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    8/13/25 6:51:24 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BHC
    $KE
    SEC Filings

    View All

    Bausch Health Companies Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Bausch Health Companies Inc. (0000885590) (Filer)

    8/15/25 3:18:06 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Kimball Electronics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Kimball Electronics, Inc. (0001606757) (Filer)

    8/13/25 5:15:57 PM ET
    $KE
    Electrical Products
    Technology

    SEC Form PRE 14A filed by Bausch Health Companies Inc.

    PRE 14A - Bausch Health Companies Inc. (0000885590) (Filer)

    8/13/25 8:04:33 AM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BHC
    $KE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Kimball Electronics downgraded by Sidoti

    Sidoti downgraded Kimball Electronics from Buy to Neutral

    8/15/24 7:57:54 AM ET
    $KE
    Electrical Products
    Technology

    Bausch Health downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Bausch Health from Neutral to Underweight and set a new price target of $3.00 from $9.00 previously

    8/2/24 7:25:50 AM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Raymond James initiated coverage on Bausch Health with a new price target

    Raymond James initiated coverage of Bausch Health with a rating of Mkt Perform and set a new price target of $8.00

    7/10/24 8:35:33 AM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BHC
    $KE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Kimball Electronics Reports Q4 Results With Solid Finish to the Fiscal Year; Company Provides Guidance for Fiscal 2026

    Fourth Quarter 2025 Highlights Net sales totaled $380.5 million, a 2% sequential increase compared to Q3 Operating income of $16.5 million, or 4.3% of net sales Adjusted operating income of $19.6 million, or 5.2% of net sales Inventory of $273.5 million, a reduction of $23.1 million in the quarter Cash generated from operating activities of $78.1 million, the sixth consecutive quarter of positive cash flow Borrowings on credit facilities of $147.5 million, a $31.3 million decrease from Q3 Cash Conversion Days of 85, the lowest result in three years Kimball Electronics, Inc. (NASDAQ:KE) today announced financial results for the fourth quarter and fiscal year ended Jun

    8/13/25 4:45:00 PM ET
    $KE
    Electrical Products
    Technology

    Kimball Electronics, Inc. Announces Date For Reporting Fourth Quarter and Fiscal Year 2025 Financial Results

    Kimball Electronics, Inc. (NASDAQ:KE) today announced that it will report fourth quarter and fiscal year 2025 financial results on Wednesday, August 13, 2025, after the closing of the market. The company will host a conference call and live webcast to review the results on Thursday, August 14, 2025, at 10:00 a.m. Eastern Time. The telephone number to access the conference call is 877-407-8293 / +1 201-689-8349. A live webcast of the conference call can be accessed at investors.kimballelectronics.com. For those unable to participate in the live webcast, a replay will be archived at investors.kimballelectronics.com. About Kimball Electronics, Inc. Kimball Electronics is a global, m

    7/31/25 3:05:00 PM ET
    $KE
    Electrical Products
    Technology

    Gateway Group Announces Preliminary Sponsors and Presenting Companies for 2025 Gateway Conference

    NEWPORT BEACH, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Gateway Group ("Gateway"), a leading financial communications and digital media advisory firm, today announced the initial sponsors and presenting companies confirmed for its annual Gateway Conference taking place at the Four Seasons Hotel in San Francisco on September 3rd and 4th. The conference is expected to host more than 300 institutional investors and analysts for two days of company presentations and curated one-on-one meetings with executives from high-growth public and private companies across the tech, AI, cleantech, consumer, financial services, and industrials sectors. "We appreciate the strong support from our sponsors

    7/30/25 8:30:00 AM ET
    $ACNT
    $AIRG
    $AKA
    Steel/Iron Ore
    Industrials
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $BHC
    $KE
    Financials

    Live finance-specific insights

    View All

    Kimball Electronics Reports Q4 Results With Solid Finish to the Fiscal Year; Company Provides Guidance for Fiscal 2026

    Fourth Quarter 2025 Highlights Net sales totaled $380.5 million, a 2% sequential increase compared to Q3 Operating income of $16.5 million, or 4.3% of net sales Adjusted operating income of $19.6 million, or 5.2% of net sales Inventory of $273.5 million, a reduction of $23.1 million in the quarter Cash generated from operating activities of $78.1 million, the sixth consecutive quarter of positive cash flow Borrowings on credit facilities of $147.5 million, a $31.3 million decrease from Q3 Cash Conversion Days of 85, the lowest result in three years Kimball Electronics, Inc. (NASDAQ:KE) today announced financial results for the fourth quarter and fiscal year ended Jun

    8/13/25 4:45:00 PM ET
    $KE
    Electrical Products
    Technology

    Kimball Electronics, Inc. Announces Date For Reporting Fourth Quarter and Fiscal Year 2025 Financial Results

    Kimball Electronics, Inc. (NASDAQ:KE) today announced that it will report fourth quarter and fiscal year 2025 financial results on Wednesday, August 13, 2025, after the closing of the market. The company will host a conference call and live webcast to review the results on Thursday, August 14, 2025, at 10:00 a.m. Eastern Time. The telephone number to access the conference call is 877-407-8293 / +1 201-689-8349. A live webcast of the conference call can be accessed at investors.kimballelectronics.com. For those unable to participate in the live webcast, a replay will be archived at investors.kimballelectronics.com. About Kimball Electronics, Inc. Kimball Electronics is a global, m

    7/31/25 3:05:00 PM ET
    $KE
    Electrical Products
    Technology

    Kimball Electronics Reports Q3 Results and Reiterates Guidance for Fiscal 2025 With Sales and Operating Income Expected at High-End of Range; Company Adds New Facility to Support Strategy to Drive Growth in the Medical CMO

    Third Quarter Fiscal 2025 Highlights Net sales totaled $374.6 million Operating income of $11.7 million, or 3.1% of net sales, adjusted operating income of 4.2% Inventory of $296.6 million, a reduction of $9.6 million from Q2 Cash generated by operating activities of $30.9 million, the fifth consecutive quarter of positive cash flow Borrowings on credit facilities of $178.8 million, a $26.2 million decrease from the second quarter, and down $116 million, or 40%, in the fiscal year Kimball Electronics, Inc. (NASDAQ:KE) today announced financial results for the third quarter ended March 31, 2025. This press release features multimedia. View the full release here: https://www.busin

    5/6/25 5:31:00 PM ET
    $KE
    Electrical Products
    Technology

    $BHC
    $KE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Kimball Electronics Inc.

    SC 13G/A - Kimball Electronics, Inc. (0001606757) (Subject)

    11/12/24 3:47:56 PM ET
    $KE
    Electrical Products
    Technology

    Amendment: SEC Form SC 13G/A filed by Kimball Electronics Inc.

    SC 13G/A - Kimball Electronics, Inc. (0001606757) (Subject)

    11/4/24 11:46:47 AM ET
    $KE
    Electrical Products
    Technology

    SEC Form SC 13G filed by Bausch Health Companies Inc.

    SC 13G - Bausch Health Companies Inc. (0000885590) (Subject)

    8/30/24 6:12:52 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BHC
    $KE
    Leadership Updates

    Live Leadership Updates

    View All

    Bausch Health Appoints New Chief Medical Officer and Head of R&D

    LAVAL, QC / ACCESSWIRE / December 2, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is pleased to announce the appointment of Jonathan Sadeh M.D., M.Sc as Executive Vice President, Chief Medical Officer and Head of R&D. This strategic addition to our leadership team underscores our commitment to innovation, excellence, and enriching lives.Jonathan brings a wealth of experience and a proven track record of success both as a physician-scientist and a leader in the pharmaceutical industry. With over 20 years of expertise in clinical research and drug development, he has consistently demonstrated the ability to drive growth and foster innovation. Most recently, at Bristol-Meyers Squibb,

    12/2/24 8:00:00 AM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    PureTech Appoints Michele Holcomb, PhD, to Board of Directors

    Strategic healthcare leader brings more than 30 years of global experience to PureTech's Board following notable positions with Cardinal Health, Teva Pharmaceuticals and McKinsey & Company PureTech Health plc (NASDAQ:PRTC, LSE: PRTC))) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announced that Michele Holcomb, PhD, will join its board of directors as an independent non-executive director. Dr. Holcomb's appointment will take effect as of September 23, 2024. She brings more than 30 years of expertise leading global healthcare companies through strategic inflection points and preparing in

    8/22/24 2:00:00 AM ET
    $KE
    $PRTC
    Electrical Products
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Averna Expands its Asian and North American Footprint with the Acquisition of Global Equipment Services, Inc. from Kimball Electronics, Inc.

    600 new employees will be based in Asia and the U.S., with offices in Vietnam, China, India, Japan and Silicon Valley. MONTREAL, Aug. 1, 2024 /PRNewswire/ - Averna, a leading global test & quality solutions provider, announced the acquisition of Global Equipment Services, Inc. (GES), a division of Kimball Electronics, Inc. (NASDAQ:KE) specialized in automation, test and measurement solutions for industries such as consumer electronics, semiconductor and medical devices. This strategic acquisition combines both companies' strengths and footprint to create one of the largest in

    8/1/24 9:17:00 AM ET
    $KE
    Electrical Products
    Technology